Skip to main content
. 2012 May 22;7(5):e37542. doi: 10.1371/journal.pone.0037542

Figure 3. NMDA receptors mediate DHR.

Figure 3

(A) The potentiation associated with DHR at an ISI of 300 ms (left) is completely eliminated after application of AP-5 (right). (B) The potentiation associated with DHR at an ISI of 200 ms (left) is also attenuated after application of the NR2B subunit selective antagonist, ifenprodil (right).